Complete a comparative financial analysis of Johnson & Johnson (JNJ) and Baxter International, Inc
Use financial data reported as of December 31, 2018.
After completing data entry in this first tab, move to the second tab to document your conclusions.
Comparative Financial Analysis:
Johnson & Johnson (JNJ) vs Baxter International, Inc. (BAX)
JNJ
BAX
Current assets
46,033
5,919
Total assets
152,954
15,641
Average total assets
155,129
16,376
Average net receivables
13,794
1,892
Current liabilities
31,230
2,836
Total liabilities
93,202
7,847
Average total liabilities
95,173
7,917
Revenue
81,581
11,127
Cash provided by operations
22,201
2,096
81,581
11,127
Gross profit
54,595
4,816
Net income
15,297
1,624
Preferred stock dividends
0
0
Average common stockholders' equity
59,956
8,459
Liquidity Metrics
Current ratio
1.47
2.09
Accounts receivable turnover (receivables turnover ratio)
5.91
5.88
Average collection period (average age of receivables) -- in days
62
62
Solvency Metrics
Debt to total assets ratio
0.61
0.50
Cash debt coverage ratio
0.23
0.26
Profitability Metrics
Gross profit ratio
0.67
0.43
Profit margin ratio
0.19
0.15
Return on assets ratio (ROA)
0.10
0.10
